Multistage carcinogenesis in the skin

Journal of Investigative Dermatology Symposium Proceedings

Volumn 1, Issue 2, 1996, Pages 147-150

  Yuspa, Stuart H ^a   Dlugosz, Andrzej A ^a   Denning, Mitchell F ^a   Click, Adam B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Evidermal growth factor recep tor; Keratinocvtes; Protein kinase c; Transforming growth factor

Indexed keywords

CALCIUM; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; GENETICS; HUMAN; MOUSE; PAPILLOMA; PHYSIOLOGY; PRECANCER; REVIEW; SKIN TUMOR;

ANIMALS; CALCIUM; HUMANS; MICE; PAPILLOMA; PRECANCEROUS CONDITIONS; RNA, MESSENGER; SKIN NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030112314     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Aldaz CM, Cond CJ, Larchcr F, Trono D, Roop DR, Chesncr J, Whitehead T, Slaga T, J: Sequential development of aneuploîdy, keratin modification and gamma-glutamyltransferase expression in mouse skin papillomas. Cancer Res 48:3253-3257, 1988
2. Aldaz CM, Trono D, Larcher F, Slaga TJ, Conti C, J: Sequential trisomization of chromosomes 6 and 7 in mouse skin prernalignant lesions. Mol Carcinôg 2:22-26, 1989
3. Blumberg PM, Acs G, Acs P, Areces LB, Kazanietz MG, Lewin NE, Szallasi , Z: Protein kin a se C in cell signaling: strategies for the development of selective inhibitors. In: Doherty N (ed.). Inβammation: Mechanisms and TJierapentics. Birkhauser Verlag, Basel, 1995, pp 87-100
4. Bremner R, Baimain , A: Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of hetcrozygosity on mouse chromosome 7. Cell 61:407-417, 1990
5. Brown K, Buchmann A, Balmain , A: Carcinogen-induced mutations in the mouse c-Ha-nu gene provide evidence of multiple pathways for tumor progression. Proc Hat! Acad Sci USA 87:538-542, 1990
6. Cheng C, Kilkenny AE, Roop D, Yuspa S, H: The v-ras oncogene inhibits the expression of differentiation markers and facilitates expression of cytokeratins 8 and 18 in mouse keratinocytes. Mot Caninog 3:363-373, 1990
7. Cheng C, Tennenbaum T, Dempsey PJ, Coffey RJ, Yuspa SH, Dlugosz A, A: Epidermal growth factor receptor ligands regulate keratin 8 expression in keratinocytes, and transforming growth factor a mediates the induction of keratin 8 by the v-nHa oncogene. Cell Growth Differ 4:317-327, 1993
8. Cui W, Kemp CJ, Duffie E, Balmain A, Akhurst R, J: Lack of transforming growth factor-β, expression in benign skin tumors of p53nu" mice is prognostic for a high risk of malignant conversion. Cancer Res 54:5831-5836, 1994
9. Deng C, Zhang P, Harper \V, Elledge SJ, Leder , P: Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in Gl checkpoint control. Cell 82:675-684, 1995
10. Denning MF, Dlugosz AA, Howett MK, Yuspa S, H: Expression of an oncogenic r11"1 gene in murine keratinoctyes induces tyrosine phosphorylation and reduced activity of protein kinase C S.JBwl Chein 268:26079-26081, 1993
11. Dlugosz AA, Cheng C, Williams EK, Darwiche N, Dempsey PJ, Mann B, Dünn AR. Coffey RJ, Jr., Yuspa S, H: Autocrine transforming growth factor a is dispensible for v-rMHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands. Cancer Res 55:1883-1893, 1995
12. Dlugosz AA, Cheng C, Williams EK, Dharia AG, Denning MF, Yuspa S, H: Alterations in murine. keratinocyte differentiation induced by activated rastl genes are mediated by protein kinase C-cr. Cancer Res 54:6413-6420, 1994
13. Dlugosz AA, Mischak H, Mushinski JF, Yuspa S, H: Transcripts encoding protein kinase C alpha, delta, epsilon, zêta, and eta are expressed in basal and differentiating mouse kerarinocytes in vitro and exhibit quantitative changes in neoplastic cells. Mol Cardnog 5:286-292, 1992
14. Dlugosz AA, Yuspa S, H: Coordinate changes in gene expression which mark the spïnous to granular cell transition in epidermis are regulated by protein kinase C. J Cell Diol 120:217-225, 1993
15. Dlugosz AA, Yuspa S, H: Protein kinase C regulates kerarinocyte transglutaminase (TGjJ gene expression in cultured primary mouse epidermal keratinocytes induced to terminally differentiate by calcium. J Invest Damatol 102:409-414, 1994
16. Domann FE, Jr., LevyJP, FinchJS, Bowden G, T: Constitutive AP-1 DNA binding and trans activa ting ability of malignant but not benign mouse epidermal cells. Mol Camnog 9:61-66, 1994
17. Fowlis DJ, Flanders KC, Duffie E, Baimain A, Akhurst R, J: Discordant transforming growth factor βl RNA and protein localization during chemical carcinogenesïs of the skin. Cell Groirth Di/cr 3:81-91, 1992
18. Click AB, Kulkami AB, Tennenbaum T, Hennings H. Flanders KC, O'Reilly M, Sporn MB, Karlsson S, Yuspa S, H: Loss of expression of transforming growth factor βin skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Set USA 90:6076-6080, 1993a
19. Click AB, Lee MM, Darvviche N, Kulkarni AB, Karlsson S, Yuspa S, H: Targeted deletion of the TGF-β1 gene causes rapid progression to squamous cell carci-noma. Genes Dcv 8:2429-2440, 1994
20. Click AB, Tennenbaum T, Hennings H, Yuspa S, H: Loss of TGF-β expression is a critical component of malignant progression in multistage carcinogenesïs of the mouse epidermis. In: Cittadinï A (ed.). Molecular Oncology and Clinical Applications, Springer-Verlag, New York, 1993b, pp 49-57
21. Goodnight J, Mischak H, Mushinski J, F: Selective involvement of protein kînase C isozymes in differentiation and neoplastic transformation. Aâv Cancer Res 64:159209, 1994
22. Greenhalgh DA, Welty DJ, Player A, Yuspa S, H: Two oncogenes, \-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinomas. Proc Natl Acad Sci USA 87:643-647, 1990
23. Hennings H, Shores R, Balaschak M, Yuspa S, H: Sensitivity of subpopulations of mouse skin papillomas to malignant conversion by urethane or 4-nitroquinoline A-oxide. Canter Res 50:653-657, 1990
24. Hennings H, Shores R, Mitchell P, Spanglcr EF, Yuspa S, H: Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesïs 6:1607-1610, 1985
25. Lee E, Punnoncn K, Cheng C, Click A, DIugosz A, Yuspa S, H: Analysis of phospholipid metabolism in murinc keratinocytes transformed by the v-ras oncogene: relationship of phosphatidylinositol turnover and cytokine stimulation to the transformed phenotype. Carcinogenesïs 13:2367-2373, 1992
26. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty T, D: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935, 1992
27. Maruta H, Burgess A, W: Regulation of the Ras signalling network. Bioessays 16:489 - 496, 1994
28. Missero C, Ramon C, Dotto G, P: Escape from transforming growth factor βcontrol and oncogene cooperation in skin tumor development. Proc iVa// Acad Sci USA 88:9613-9617, 1991
29. Navarro P, Gömez M, Pizarro A, Gamallo C, Quintanïlla M, Cano , A: A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis. J Cell Biol 115:517-533, 1991
30. Otto E, McCord S, Tlsty T, D: Increased incidence of CAD gene amplification in tumorigenic rat lines as an indicator of genomic instability of neoplastic cells. J Biol C/iwfi 264:3390-3396, 1989
31. Tennenbaum T, Belanger AJ, Guck AB, Tamura R, Quaranta V, Yuspa S, H: A splice variant of cx6 integrin is associated with malignant conversion in mouse skin tumorigenesis. Pnx Katl Acad Sci USA 92:7041-7045, 1995
32. Tennenbaum T, Weiner AK, Belanger AJ, Click AB, Hennings H, Yuspa S, H: The suprabasal expression of a6β4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis. Cancer Res 53:4803-4810, 1993
33. Tennenbaum T, Yuspa SH, Grover A, Castronovo V, Sobel ME, Yamada Y, De Luca L, M: Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor progression. Cancer Res 52:2966-2976, 1992
34. Tlsty TD, Margolin BH, Lum , K: Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis. Proc Natl Acad Sci USA 86:9441-9445, 1989
35. Urabe A, Nakayama J, Taniguchi S, Terao H, Hori , Y: Expression of the c-fos oncogene in chemically-induced mouse tumours and in human skin tumours. J Patliol 168:281-286, 1992
36. Vassar R, Hutton ME, Fuchs , E: Transgcnic overexpression of transforming growth factor a bypasses the need for c-Ha-r
37. Wahl CM, Padgett RA, Stark G, R: Gene amplification causes overproduction of the first three enzymes of UM P synthesis in N-(phosphonacetyi)-L-a$part3te-resistant hamster cells. J Biol Chan 254:8679-8689, 1979
38. Wang XJ, Greenhalgh DA, Eckhardt JN, Rotlinagel JA, Roop D, R: Epidermal expression of transforming growth factor-alpha in transgenic mice: induction of spontaneous and 12-O-tetradecanoyIphorboI-13-acetate-induccd papillomas via a mechanism independent of Ha-ras activation or overexpression. Mot Carcinog 10:15-22, 1994
39. Ha oncogene. Cancer Res 54:5584-5592, 1994
40. Wright JA, Smith HS. Watt FM, Hancock MC, Hudson DL, Stark G, R: DNA amplification is rare in normal human cells. Proc Xatl Acad Sci USA 87:1791-1795, 1990
41. Yin Y, Tainsky MA, BischotFFZ, Strong LC, Wahl G, M: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948, 1992
42. Yuspa S, H: The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis-Thirty-third G.H.A. Clowes Memorial Award Lecture. CattccrRa 54:1178-1189, 1994